$3.50
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company is headquartered in South Orange, New Jersey and currently employs 36 full-time employees. The company went IPO on 2004-09-21. The firm provides water filtration products and services, along with water-quality education. In the medical markets, it sells water filtration products. In the commercial market, it manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, heavy metals, chemical compounds, scale build-up in downstream equipment, and various other contaminants. Its products are marketed primarily to the food service, hospitality, convenience store, and healthcare markets. These commercial products are also marketed in medical markets as supplemental filtration to its medical filters. Its filters are primarily used in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, and in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate.
Country

US

CEO

Mr. Robert Banks

IPO date

2004

Employees

36

ISIN

US6406714005

Key stats

Open

$3.37

Volume

7.11K

Market cap

$35.94M

Prev. close

$3.50

Impl / hst vl

-

Open interest

$0.00

$3.28

Day’s Range

$3.50

$2.66

52W Range

$5.46

Valuation

55
Valuation score
Fairly Valued
P/E
46.17
P/S
1.87
P/B
3.35
Current ratio
4.55
Debt / Equity
-0.37
ROE
7.66%
Gross margin
57.43%
Income growth
125.81%
FCF growth
-826.52

Analysts estimates

Consensus rating
Buy

The average rating from top 5 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$7.14
The top 4 analysts forecasts that 12-month price may increase by 104.00%, with a low of $6.06 and a high of $8.40
$6.06
Low
$7.14
Avg
$8.40
High
Current price

Earnings

Q1 ‘26 revenue
$5.21M
Q1 ‘26 net income
$140.00K
Revenue
Net income
Previous EPS
$0.01
Estimate EPS
$0.00
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply